Pharvaris (PHVS) EBIT (QoQ) (2020 - 2026)
Pharvaris (PHVS) EBIT (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Pharvaris | 2.17 Bn | 1.88 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -100.00% |
| Dec 31, 2025 | 105,901,915,336,293,433,344.00% |
| Sep 30, 2025 | 100.00% |
| Jun 30, 2025 | 100.00% |
| Mar 31, 2025 | -31,365,346,960,083.42% |
| Dec 31, 2024 | -239.89% |
| Sep 30, 2024 | -30.32% |
| Jun 30, 2024 | -3.85% |
| Mar 31, 2024 | 99.99% |
| Dec 31, 2023 | -1,006,884.84% |
| Sep 30, 2023 | -7.53% |
| Jun 30, 2023 | 100.00% |
| Mar 31, 2023 | -29,308,348.24% |
| Dec 31, 2022 | 100.00% |
| Sep 30, 2022 | -98,931,948.95% |
| Jun 30, 2022 | -4.90% |
| Mar 31, 2022 | 55.43% |
| Dec 31, 2021 | -210.44% |
| Sep 30, 2021 | -2.58% |
| Jun 30, 2021 | -7.27% |